In a recent study, patients who regularly exercised were less likely to gain back weight a year after regular injections
Semaglutide has also been shown to be associated with superior adherence compared to other GLP-1 RAs [23, 24]
Compounded semaglutide and tirzepatide from licensed 503A pharmacies contain identical active pharmaceutical ingredients as brand versions and show equivalent clinical effectiveness
There is no data on the safety and efficacy of compounded tirzepatide alone or in combination with these other ingredients
Our expert nutritionist, Mark Gilbert, explains how a reduced appetite and lower overall fluid intake can increase the risk of dehydration, and how to ensure users stay hydrated through the heatwaves and warmer temperatures that are becoming more common across the UK
Tirzepatide is the chemical name of the active ingredient, while Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management) are the proprietary brand names manufactured by Eli Lilly and Company